Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
purdue pharma
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
merck
pfizer
alzheimer's disease
biogen
biotech
cancer
deals
diagnostics
genfit
gilead sciences
What
bio
drug
4
×
roundup
pricing
week
acquisitions
aducanumab
advanced
advantages
alzheimer’s
amyloid
angst
arrival
award
bagged
bar
biggest
billions
biogen
biogen’s
brammer
brings
build
buy
cancer
ceo
company’s
daniel
data
death
debut
decades
dems
dyne’s
effects
expect
failure
felt
gamble
gilead
Language
unset
Current search:
drug
×
" purdue pharma "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
